Every SEC Form 3/4/5 on record for this filer (CIK 1625110) — 4 issuers, 25 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Director | 2021-07-16 → 2026-06-15 | 9 | −$194,636 |
| VERV | Verve Therapeutics, Inc. | Chief Financial Officer | 2021-11-30 → 2025-07-28 | 11 | −$35,619 |
| AVTE | Aerovate Therapeutics, Inc. | Director · lapsed | 2021-07-19 → 2024-06-07 | 5 | — |
| VYGR | Voyager Therapeutics, Inc. | Chief Financial Officer · lapsed | 2018-06-15 → 2021-03-23 | 9 | −$91,204 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PBYI | 2026-06-12 | Sell | 11,610 | $7.20 | $83,592 | 90,780 |
| PBYI | 2025-06-13 | Sell | 11,610 | $3.40 | $39,474 | 75,390 |
| VERV | 2025-04-02 | Sell | 3,350 | $4.15 | $13,903 | 13,280 |
| VERV | 2024-12-02 | Sell | 555 | $5.64 | $3,130 | 5,380 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.
